DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-003676-31-FR (EUCTR)	31/12/2019	25/04/2018	Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS	Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS	Amyotrophic lateral sclerosis MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Eril® INN or Proposed INN: FASUDIL HYDROCHLORIDE Other descriptive name: FASUDIL HYDROCHLORIDE	Georg-August-Universität Göttingen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 2	France;Germany;Switzerland

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2017-003676-31-FR
(EUCTR)

31/12/2019

25/04/2018

Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS

Amyotrophic lateral sclerosis
MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

Trade Name: Eril®
INN or Proposed INN: FASUDIL HYDROCHLORIDE
Other descriptive name: FASUDIL HYDROCHLORIDE

Georg-August-Universität Göttingen

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

120

Phase 2

France;Germany;Switzerland